Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 17

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 17
---
 votes are needed to approve each proposal and what is the effect of withhold votes, abstentions and broker non-votes? The following table summarizes the minimum vote needed to approve each proposal and the effect of withhold votes, abstentions and broker non-votes.

| Proposal 

# |     | Proposal Description                                                                                                                                                 |     | Vote Required for                                                                                                                                                                       
 Approval                                                                                                                                                                                |     | Effect of Votes Withheld or Abstentions                                                                     |     |                         Effect of Broker 
                                Non-Votes |
| 1          |     | Election of Directors (1) (3)                                                                                                                                        |     | The plurality of the votes of the holders of shares present and entitled to vote on the proposal. The two nominees receiving the most “FOR” votes will be elected as Class I directors. |     | Votes withheld will not be counted as votes cast and will have no effect.   Abstentions are not applicable. |     | Broker non-votes will have no effect.(3) |
| 2          |     | Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2025 (2) |     | “FOR” votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter will ratify the appointment.                          |     | Abstentions will have the same effect as votes “AGAINST” this proposal.                                     |     |                                       -2 |

17

| (1) | The Board does not endorse the Mangless Nominees and recommends that you vote “FOR” the election of the two nominees proposed by the Board. |

| (2) | Typically, this proposal is considered to be a “routine” matter and we would not expect any broker non-votes. Typically, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other nominee that holds your shares, your broker, bank or other nominee generally has discretionary authority to vote your shares on this proposal. However, to the extent that Mr. Mangless provides a blue proxy card or voting instruction form to stockholders who hold their shares in “street name,” Proposal 2 included in this proxy statement will be a “non-routine” matter with respect to such stockholders, and brokers will not have discretionary voting authority to vote on either of the proposals presented at the Annual Meeting. If, however, Mr. Mangless does not provide a blue proxy card or voting